Neurelis, Inc.

Pharmaceutical ManufacturingCalifornia, United States51-200 Employees

Neurelis, Inc. is a pharmaceutical manufacturer focused on developing therapeutics for neurological conditions, with a emphasis on enabling patients to manage their journeys more effectively. Its portfolio includes VALTOCO, a diazepam nasal spray, and the company pursues additional programs such as NRL-1049, a ROCK inhibitor aimed at cerebral cavernous malformations, reflecting a broader commitment to innovative neurology treatments. Based in San Diego, California, the company operates within the pharmaceutical industry and positions itself as a developer of life-changing therapeutics intended to improve patient control and quality of life.

Neurelis engages with the epilepsy community and related medical stakeholders through participation in awareness events and educational forums, signaling a focus on patient-centered care and collaboration with healthcare providers and families. The company maintains a relatively small to mid-size footprint, emphasizing research, development, and clinical advancement activities. Its recent communications highlight ongoing product development and involvement in epilepsy-related events, underscoring its role as a specialized player within neurological therapeutics.

Sign up for free to view info

Email Format Employee directory